CLINICAL CHARACTERISTICS AND RENAL RISK OF PATIENTS WITH CHRONIC KIDNEY DISEASE: REAL-WORLD EVIDENCE FROM THE ICAREME GLOBAL REGISTRY

被引:0
|
作者
Arici, Mustafa [1 ]
Pollock, Carol [2 ]
Goncalves, Susana [3 ]
Vasnawala, Hardik [4 ]
Hadaoui, Ahmed [5 ]
机构
[1] Hacettepe Univ, Fac Med, Dept Nephrol, Ankara, Turkiye
[2] Univ Sydney, Royal North Shore Hosp, Kolling Inst, Camperdown, NSW, Australia
[3] AstraZeneca Int, Med Affairs, Buenos Aires, Argentina
[4] AstraZeneca Int, Med Affairs, Bengaluru, India
[5] AstraZeneca Algeria, Med Affairs, Buenos Aires, Argentina
关键词
D O I
暂无
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
6054
引用
收藏
页码:I544 / I545
页数:2
相关论文
共 50 条
  • [1] Real-world evidence for steroidal mineralocorticoid receptor antagonists in patients with chronic kidney disease
    Folkerts, Kerstin
    Millier, Aurelie
    Smela, Beata
    Olewinska, Elzbieta
    Schmedt, Niklas
    Mernagh, Paul
    Kovesdy, Csaba P.
    JOURNAL OF NEPHROLOGY, 2023, 36 (04) : 1135 - 1167
  • [2] Real-world evidence for steroidal mineralocorticoid receptor antagonists in patients with chronic kidney disease
    Kerstin Folkerts
    Aurelie Millier
    Beata Smela
    Elzbieta Olewinska
    Niklas Schmedt
    Paul Mernagh
    Csaba P. Kovesdy
    Journal of Nephrology, 2023, 36 : 1135 - 1167
  • [3] Worsening of kidney function in patients with atrial fibrillation and chronic kidney disease: evidence from the real-world CALLIPER study
    Vaitsiakhovich, Tatsiana
    Coleman, Craig, I
    Kleinjung, Frank
    Vardar, Burcu
    Schaefer, Bernhard
    CURRENT MEDICAL RESEARCH AND OPINION, 2022, 38 (06) : 937 - 945
  • [4] FEASIBILITY OF IDENTIFYING DEMOGRAPHIC AND CLINICAL INSIGHTS FOR PATIENTS WITH CHRONIC KIDNEY DISEASE FROM REAL-WORLD DATA
    Madaj, K.
    Brauneis, J.
    Menon, J.
    Vossen, C.
    VALUE IN HEALTH, 2024, 27 (06) : S392 - S392
  • [5] Baseline Characteristics and Real-world Treatment Patterns in People with T2D in India: Results from iCaReMe Registry
    Saboo, B.
    Kadam, Y.
    Vasnawala, H.
    Bharath, H.
    Sarda, S.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2023, 197
  • [6] Baseline characteristics of patients treated with vedolizumab in Taiwan: real-world evidence from TSIBD registry
    Lin, Wei-Chen
    Chang, Chung-Hsin
    Tu, Chia-Hung
    Feng, I-Che
    Chou, Jen-Wei
    Chung, Chen-Shuan
    Shieh, Ming-Jium
    Yen, Hsu-Heng
    Liu, Yuh-Hwa
    Tai, Wei-Chen
    Wu, Deng-Chyang
    Hsu, Wen-Hung
    Lu, Chien-Yu
    Lu, Lung-Sheng
    Tsai, Tzung-Jiun
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 304 - 305
  • [7] Chronic kidney disease and hepatitis C mutually advance liver and renal disease progression: real-world evidence from the United States
    Tran, Tram T.
    Sanchez, Yuri
    Hayes, Oscar A.
    Marx, Steven
    HEPATOLOGY, 2017, 66 : 467A - 467A
  • [8] Predicting the early risk of chronic kidney disease in patients with diabetes using real-world data
    Stefan Ravizza
    Tony Huschto
    Anja Adamov
    Lars Böhm
    Alexander Büsser
    Frederik F. Flöther
    Rolf Hinzmann
    Helena König
    Scott M. McAhren
    Daniel H. Robertson
    Titus Schleyer
    Bernd Schneidinger
    Wolfgang Petrich
    Nature Medicine, 2019, 25 : 57 - 59
  • [9] Real-World Multicenter Registry to Determine Management and Quality of Care of Patients with Type 2 Diabetes, Hypertension, Heart Failure and/or Chronic Kidney Diseases in China (iCaReMe China)
    Xiaoling Cai
    Wenjia Yang
    Bo Feng
    Qiuhe Ji
    Ming Liu
    Yanbing Li
    Nanwei Tong
    Ningling Sun
    Minghui Zhao
    Linong Ji
    Advances in Therapy, 2025, 42 (3) : 1600 - 1609
  • [10] Predicting the early risk of chronic kidney disease in patients with diabetes using real-world data
    Ravizza, Stefan
    Huschto, Tony
    Adamov, Anja
    Boehm, Lars
    Buesser, Alexander
    Floether, Frederik F.
    Hinzmann, Rolf
    Konig, Helena
    McAhren, Scott M.
    Robertson, Daniel H.
    Schleyer, Titus
    Schneidinger, Bernd
    Petrich, Wolfgang
    NATURE MEDICINE, 2019, 25 (01) : 57 - +